Dual Surgeon Operating to Prevent Colorectal Cancer Surgery Skill Fatigue in Rural Surgery-A Prospective Audit of 154 Patients.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
surgery for colorectal cancer during the audit period (November 2015 to February 2025)
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The approach allows for more than 85% of all procedures to be done minimally invasive. Dual-surgeon operating helps to mitigate skill fade as well as loss of confidence for surgeons performing complex colorectal procedures in a low/medium volume setting.
[BACKGROUND] Skill maintenance for rural surgeons is challenging.
- 표본수 (n) 92
- p-value p = 0.0038
- p-value p = 0.02
APA
Wichmann MW, McCullough TK, et al. (2025). Dual Surgeon Operating to Prevent Colorectal Cancer Surgery Skill Fatigue in Rural Surgery-A Prospective Audit of 154 Patients.. ANZ journal of surgery, 95(10), 2060-2065. https://doi.org/10.1111/ans.70272
MLA
Wichmann MW, et al.. "Dual Surgeon Operating to Prevent Colorectal Cancer Surgery Skill Fatigue in Rural Surgery-A Prospective Audit of 154 Patients.." ANZ journal of surgery, vol. 95, no. 10, 2025, pp. 2060-2065.
PMID
40936415 ↗
Abstract 한글 요약
[BACKGROUND] Skill maintenance for rural surgeons is challenging. Surgery for colorectal disease requires a specialised skill set. Dual surgeon operating in low or medium volume centres may mitigate skill fade and improve surgical outcomes. There is a paucity of data on the outcomes of dual surgeon operating.
[METHODS] Prospective audit of outcomes after dual surgeon operations for colorectal disease in a non-metropolitan surgical centre. Results are compared with treatment outcomes in the same hospital prior to the dual surgeon approach. Ethics approval CALHN Human Research Ethics Committee (Ref # 12041).
[RESULTS] One hundred fifty-four patients underwent surgery for colorectal cancer during the audit period (November 2015 to February 2025). 60% of the patients were male (N = 92); median age was 70 years. Compared to the historic control (N = 233) there was a significant reduction in wound infections (3.2% vs. 12.4%, p = 0.0038), complications (24% vs. 40%, p = 0.02), intraoperative blood loss (60 vs. 250 mL, p < 0.001) and length of stay (6 vs. 8 days, p < 0.001). The lymph node yield was significantly increased (17 vs. 13, p < 0.001). Significantly more patients underwent laparoscopic colorectal surgery (87% vs. 23.6%, intention to treat, p < 0.00001) with a reduction of conversions (6% vs. 11%, p = 0.28). Outcomes were improved but did not reach statistical significance with regard to 30-day mortality (0.64% vs. 0.86%, p = 0.82), leak rate (2.2% vs. 5.5% of procedures with anastomosis, p = 0.15) and unplanned return to theatre (4.6% vs. 7.7%, p = 0.24).
[CONCLUSIONS] Our findings confirm that two-surgeon operating is feasible and safe for the treatment of colorectal cancer. Significantly better postoperative outcomes can be achieved with regard to complications, blood loss, and length of stay. The approach allows for more than 85% of all procedures to be done minimally invasive. Dual-surgeon operating helps to mitigate skill fade as well as loss of confidence for surgeons performing complex colorectal procedures in a low/medium volume setting.
[METHODS] Prospective audit of outcomes after dual surgeon operations for colorectal disease in a non-metropolitan surgical centre. Results are compared with treatment outcomes in the same hospital prior to the dual surgeon approach. Ethics approval CALHN Human Research Ethics Committee (Ref # 12041).
[RESULTS] One hundred fifty-four patients underwent surgery for colorectal cancer during the audit period (November 2015 to February 2025). 60% of the patients were male (N = 92); median age was 70 years. Compared to the historic control (N = 233) there was a significant reduction in wound infections (3.2% vs. 12.4%, p = 0.0038), complications (24% vs. 40%, p = 0.02), intraoperative blood loss (60 vs. 250 mL, p < 0.001) and length of stay (6 vs. 8 days, p < 0.001). The lymph node yield was significantly increased (17 vs. 13, p < 0.001). Significantly more patients underwent laparoscopic colorectal surgery (87% vs. 23.6%, intention to treat, p < 0.00001) with a reduction of conversions (6% vs. 11%, p = 0.28). Outcomes were improved but did not reach statistical significance with regard to 30-day mortality (0.64% vs. 0.86%, p = 0.82), leak rate (2.2% vs. 5.5% of procedures with anastomosis, p = 0.15) and unplanned return to theatre (4.6% vs. 7.7%, p = 0.24).
[CONCLUSIONS] Our findings confirm that two-surgeon operating is feasible and safe for the treatment of colorectal cancer. Significantly better postoperative outcomes can be achieved with regard to complications, blood loss, and length of stay. The approach allows for more than 85% of all procedures to be done minimally invasive. Dual-surgeon operating helps to mitigate skill fade as well as loss of confidence for surgeons performing complex colorectal procedures in a low/medium volume setting.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Male
- Female
- Colorectal Neoplasms
- Aged
- Prospective Studies
- Clinical Competence
- Middle Aged
- Surgeons
- Postoperative Complications
- Length of Stay
- 80 and over
- Medical Audit
- Fatigue
- Laparoscopy
- audit
- colorectal cancer
- dual surgeon operating
- laparoscopic surgery
- non‐metropolitan
- rural
- two surgeon approach
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.